title: [Prevention and treatment of venous thromboembolism in patients with cancer].
authors.affiliation: Klinik für Hämatologie, Onkologie, Immunologie, Palliativmedizin, Infektiologie und Tropenmedizin, Klinikum Schwabing, München. sabine.struve@klinikummuenchen.de
authors.forename: S
authors.initials: S
authors.lastname: Struve
authors.forename: C-M
authors.initials: CM
authors.lastname: Wendtner
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D019317:Evidence-Based Medicine; D006493:Heparin / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D008134:Long-Term Care; D009369:Neoplasms / Q000097:blood / Q000150:complications*; D017410:Practice Guidelines as Topic; D011655:Pulmonary Embolism / Q000097:blood / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D055502:Secondary Prevention; D054556:Venous Thromboembolism / Q000097:blood / Q000517:prevention & control*; D014812:Vitamin K / Q000037:antagonists & inhibitors
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014812:Vitamin K; D006493:Heparin